Pre-IPO Huge Dental Limited - The Business and the Concerns Behind
​Import substitution and cost effectiveness drive HUGE's performance growth, but competing in non-advantageous areas may require price reduction...
Pre-IPO Hangzhou Jiuyuan Gene Engineering (PHIP Updates) - The Future Prospects Are Not Optimistic
​Jiuyuan's growth momentum is stalling due to VBP. Guyoudao and JY29-2 face competition and uncertainty. Market value may surpass Qyuns. Future...
Pre-IPO Hangzhou Jiuyuan Gene Engineering - Old Pipelines Are Difficult to Bring New Breakthroughs
Jiuyuan's pipelines lack high moat since most are generic pharmaceuticals and relatively old products. If its GLP-1s fail to show superior clinical...
Smartkarma North Asia Weekly: Alibaba Antitrust, OFAC Clarification, China Logistics, & Kuaishou IPO
In this edition of the Smartkarma North Asia Weekly, it summarizes some of the top insights on Smartkarma in the past week covering Japan, HK...
Industry Report - Insights on China Dental Care Industry
This article analyzed the China dental care industry in terms of market potential, oral instruments (implants, invisible orthodontics and CBCT),...
No more insights